Satoshi Ozaki - Concepedia

Author

Satoshi Ozaki

Also Known As

Ferreira, Marcelo, Lindenbaum, S J, Masafumi Morimoto, Ozaki, S, Ozaki, S., Ozaki, Satoshi, R. Heese, S OZAKI, S Ozaki, S Ozaki MD

258

Publications

7.6K

Citations

H-Index

192

Concepts

All Affiliations

Food Research Institute Brookhaven National Laboratory Yamaguchi University

About

Satoshi Ozaki is an author at Food Research Institute specializing in medicine, natural sciences, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	38	3K
2	Natural Sciences	18	23	2K
3	Engineering	14	18	765
4	Health Sciences	6	6	198
5	Education	2	2	44

Satoshi Ozaki

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Clearance of Circulating Endothelin-1 by ETB Receptors in Rats Takahiro Fukuroda, Tatsuya Fujikawa, Satoshi Ozaki, Biochemical and Biophysical Research Communications Etb ReceptorsMedicinePhysiologyEndothelial DysfunctionVascular Biology	1994	624
Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Kiyofumi Ishikawa, M. Ihara, Kazuhito Noguchi, Proceedings of the National Academy of Sciences Molecular PharmacologyEta-selective AntagonistFunctional SelectivityMedicineVascular Pharmacology	1994	573
Small-Angle Elastic Scattering of Protons and Pions, 7-20 BeV/<i>c</i> K. J. Foley, S. J. Lindenbaum, W. A. Love, Physical Review Letters September 1963DoiHigh-energy Nuclear ReactionNuclear PhysicsPhysicsSmall-angle Elastic Scattering	1963	334
Antiproton and Kaon Elastic Scattering at High Energies K. J. Foley, S.J. Lindenbaum, W. A. Love, Physical Review Letters PhysicsKaon Elastic ScatteringNatural SciencesParticle PhysicsWave Scattering	1963	230
FEASIBILITY STUDY II OF A MUON BASED NEUTRINO SOURCE. Satoshi Ozaki, Michael S. Zisman Neutrino PropertyPhysicsMeasurementLepton MixingNatural Sciences	2001	227
Discovery of the First Potent and Selective Small Molecule Opioid Receptor-like (ORL1) Antagonist: 1-[(3<i>R</i>,4<i>R</i>)-1-Cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl- 1,3-dihydro-2<i>H</i>-benzimidazol-2-one (J-113397) Hiroshi Kawamoto, Satoshi Ozaki, Yoshiki Itoh, Journal of Medicinal Chemistry Drug TargetAltmetric Attention ScorePharmacotherapySystem PharmacologyExperimental Pharmacology	1999	204
Potent neuropeptide Y Y1 receptor antagonist, 1229U91: blockade of neuropeptide Y-induced and physiological food intake. Akio Kanatani, Akane Ishihara, Shuichi Asahi, Endocrinology NutritionIntracerebroventricular InjectionFood IntakeGastrointestinal Peptide HormoneMolecular Pharmacology	1996	184
Recent progress in neutrino factory and muon collider research within the Muon Collaboration Mohammad M. Alsharo’a, C. Ankenbrandt, Muzaffer Ataç, Physical Review Special Topics - Accelerators and Beams	2003	175
Elastic Scattering of Protons, Antiprotons, Negative Pions, and Negative Kaons at High Energies K. J. Foley, R. Gilmore, S. J. Lindenbaum, Physical Review Letters Negative PionsElastic ScatteringEngineeringNuclear PhysicsPhysics	1965	169
In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist Satoshi Ozaki, Hiroshi Kawamoto, Yoshiki Itoh, European Journal of Pharmacology Molecular PharmacologyBiochemistryFunctional SelectivityMedicineExperimental Pharmacology	2000	167

Page 1